Pablo Albasanz-García/LinkedIn
Jan 14, 2026, 11:26
Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mechanisms of anticancer treatment-induced arterial and venous thrombosis
This narrative review explores how cancer therapies trigger blood clots through coagulation activation, vascular damage, tumor cell death materials, and inflammation—crucial for developing better thrombosis prevention strategies.
Authors: Pablo Albasanz-García, Mark Ward, Lucy Norris
Check out this article.”
Article: Mechanisms of anticancer treatment-induced arterial and venous thrombosis
Authors: Pablo Albasanz-García, Mark P. Ward, Lucy A. Norris
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF